SlideShare a Scribd company logo
Guillaume PLANE
Provantage
®
End-To-End Solutions
NOT FOR U.S. AND CANADA AUDIENCE
Managing process
scaling and tech
transfer
2 Managing process scaling and tech transfer
Let us start with ICH Q10…
“The goal of technology transfer activities is to transfer product and process
knowledge between development and manufacturing, and within or between
manufacturing sites to achieve product realization. This knowledge forms the
basis for the manufacturing process, control strategy, process validation
approach, and ongoing continual improvement.”
 Transfers have to be performed in an organized, methodical manner, with
appropriate documentation.
 We will focus on the transfer of Drug Substance process parameters and
process knowledge (data).
Technology Transfer
3 Managing process scaling and tech transfer
Process transfers include:
• Transfer from one Process Development group to another, or to Pilot Lab
• Transfer from Process Development to clinical or commercial manufacturing
• Transfer from Process Development to external clinical manufacturing
• Transfer of commercial process between company facilities
• Transfer of commercial process to external contract manufacturing
Greater rigor and documentation are needed for the latter cases, especially transfers between companies.
Best practices discussed here cover the greater level of detail
Scale as appropriate for the situation
Scope of Process Transfers
4 Managing process scaling and tech transfer
Mobius® 2,000 L Single-Use Bioreactor Performances
Production of a mAb with a CHO-S cell line
Define Scale in Advance of Transfer
5 Managing process scaling and tech transfer
Mobius®
2000L Single Use Bioreactor Performances
Production of mAb with CHO-K1 cell line (Cellvento®
CHO 220)
6 Managing process scaling and tech transfer
1. Form tech transfer teams and governance structures, define project charter with goals and timelines
2. Consolidate process knowledge into transferable documentation
3. Gap Analysis / Risk Assessment – leads to detailed project plan
4. Tech Transfer Execution (work the plan)
5. Process “Q/q”ualification – demonstrate technical success
6. Finalize transfer: documentation, support of regulatory activities, follow-up actions, plan for ongoing technical
support, lessons learned
Process Transfer: Key Activities
Transfer does not end at completion of
Qualification lots or approval,
but extends over duration of
manufacturing
7 Managing process scaling and tech transfer
Write Request for Proposal (RFP)
• Provide sufficient detail for accurate assessment
Due Diligence
• Assess capabilities
• Capacity, facility, cGMP, personnel
• High level gap analysis
• Be ready to order long lead time equipment
• Assess feasibility if significant process changes would be required
Write contract
• Be specific on deliverables and expectations
• Ensure terms incentivize rigorous scientific behaviors
Early Planning Stage: often precedes external transfers
8 Managing process scaling and tech transfer
Key content and outcomes from this document must include:
• A well-defined team structure
• Sub-teams for different disciplines
• Connect counterparts
• Establish communication paths
• A well defined governance structure to resolve issues
• Aligned timelines, gating/review points, and goals for deliverables
• Clearly described roles and responsibilities
• Who will be responsible for ongoing support and troubleshooting throughout manufacturing?
• Clearly established success criteria
Set expectations and responsibilities between partners
Project Charter
9 Managing process scaling and tech transfer
A Process Description document with an overview of each step and key process parameters is required
• Information should be described in a site- and scale-independent manner, to focus on intrinsic process
requirements
• Site-specific details from previous process installations should also be gathered as examples
For example:
• Buffers may have been prepared in batch or via in-line dilution
• Bioreactors may have been operated with different sparger configurations
Consolidated Process Knowledge
Use an electronic file sharing system
for document hosting– not email
10 Managing process scaling and tech transfer
Additional Valuable Process Information
Materials
• BOM
• Consumables: bags, filters,
tubing, gaskets, o-rings,
etc.
• Vendors
• Grade
Analytics
• Assays used as part of mfg
process: pH, osmo,
conductivity, OD
• Assays required to support
transfer of scale-down
models
Facility & Equipment
Requirements
• URS/FRS
• Heating/cooling
• Process gas flow rates and
total capacity
• Instrumentation and control
capabilities
• Materials of construction
• Safety assessments,
hazardous material
containment/
disposal
Other Sources of
Process Information
• PD reports
• Validation reports
• Batch records / SOPs
• Historical trends of process
and product data
• License requirements
• Small scale model
instructions and data
• Spreadsheet process models
• Tacit knowledge: cell
morphology, media color,
etc.
11 Managing process scaling and tech transfer
Thorough process walk through:
• Based on Process Description document
• Assesses detailed fit of process in receiving facility
• Identifies areas where changes will be necessary or what differences are acceptable
• Guides project work plan
• Identifies needs for facility modifications
Great process learning exercise for the receiving site!
Gap Analysis
Gaps can be addressed by changing equipment,
procedures, or the process
Changes may require specific new validation studies or may
be covered through the Process Qualification validation
12 Managing process scaling and tech transfer
If you have to make process changes…
• Some process changes are inevitable based on
major differences in facility, equipment, or
operational practices
• Proper experiments must be performed to
determine acceptability of the change. Small-
scale models may be a good tool for
examining the effects of changes
• Pre-defined success criteria are key to timely
progress and decision making- Otherwise, how
do you know if the proposed change is
acceptable?
13 Managing process scaling and tech transfer
Quality Risk Management
What do we do with all these gaps we identified?
Risks are inherent in
technology transfers
Identifying, assessing, and
mitigating
- or -
accepting risks defines the
project work scope of a
transfer
From ICH Q9, two primary principles of quality risk
management are:
• Evaluation of the risk to quality should be based on scientific
knowledge and ultimately link to the protection of the patient
• The level of effort, formality, and documentation of the quality
risk management process should be commensurate with the
level of risk
14 Managing process scaling and tech transfer
Goal: To achieve readiness for process qualification
Mitigate identified risks
• Equipment/facility modifications and validations
Execute process using small scale model – qualify model
Full scale engineering or “water” runs
Author and approve manufacturing instruction documents
• Requires a well-organized system for tracking and managing edits
Training of production and support staff
Tech Transfer Execution
Work the plan…
15 Managing process scaling and tech transfer
Process “Q/q”ualification
Demonstration that the process is performing correctly at the receiving unit
This may be a formal validation exercise or a simple report following an early clinical campaign
Important to have Pre-defined Success Criteria (may or may not be part of Validation protocol)
• Key Process Performance Metrics
• Step yields, impurities, growth rates, titers, etc.
• Product Quality Ranges
• Successful Validation
At key “go/no-go” decision
points, it is helpful for parties
to have agreed in advance
on what success looks like
16 Managing process scaling and tech transfer
Review process performance
• If there are issues to be corrected, assign actions and plan the work
• If failures occurred due to flaws in the methods of transfer, amend
transfer procedures for future executions
Support Regulatory activities
• Document preparation for submissions
• Respond to questions
• Preparation for inspections
Implement systems for ongoing technical support of manufacturing
Complete all documentation
Finalize Transfer
17 Managing process scaling and tech transfer
What if you don’t have to make any changes to your process?
Provantage®
End-to-End Value
Existing Process
New Process
Re-fit Process
New Facility
- We develop your manufacturing process for you
- We fit the process to the updated template while your facility is being built
18 Managing process scaling and tech transfer
Provantage®
End-to-End Value
Proven
Templates
Innovation
Knowledge
Transfer
Tech
Transfer
19 Managing process scaling and tech transfer
Template approach
Save time and money thanks to our ClinicReady™ Template
Clarification
Affinity
Chromatography
Ultrafiltration
Sterile filtration
CEX
Chromatography
Bulk
Drug
Substance
Bioreactor
Virus removal
AEX
Chromatography
20
• At each end of stage, a « Gate Review » is performed to ensure that quality of deliverables is online
with the initial target
• The whole stage is then validated
• Intermediates Go/No Go will also occur during a stage to start activities of the next stage
• Allows a time optimization by perfoming tasks in parallel (fast-tracking)
A stage-gate approach
21
Plant Design
Equipment definition
Module definition
Integration
Final modules
Managing process scaling and tech transfer
22 Managing process scaling and tech transfer
Plant Design
23 Managing process scaling and tech transfer
A brand new facility in a little over a year
L0: GMP
Preclinical
production
L+2:
Process
development
24 Managing process scaling and tech transfer
Upstream Suites
Increased flexibility and lower cost production environment
25 Managing process scaling and tech transfer
26 Managing process scaling and tech transfer
Tech Transfer
Kick off
meeting
Team
members
Regulatory and
validation
requirements
Technical and
Quality Agreement
Planning
Communication
plan
Risk analysis
validated
Kick off meeting: Scope, transfer timelines and team members are defined
Team members: At least composed of a project manager, a technical leader and a tech transfer team
Communication plan: Deliverables
Team members with their respective responsibilities
Communication flow path
Meeting frequency
Tech transfer protocol: Equipment
Raw materials and consumables
Detailed process description including critical parameters
Analytical methods
Tech Transfer
Protocol
Reference
material provided
Tech
Transfer
report
Tech
Transfer
Closure
Experiments
Goal: Select parameters from cloning to adapt cells to our internal platform for sub-cloning step
Cloning report:
 Draft version: incomplete (raw mat.) / mistakes (% DMSO) but enough data to launch the project
 Cloning medium composition
 Cloning efficiency
 Direct contact with sending entity (SE) for further information (mail exchange)
 Technical transfer for Downstream Processing & Analytical parts but no Upstream part:
 SE did not perform a sub-cloning phase but only a cloning step
 The sub-cloning phase would not be included in a Tech transfer document (SE expertise)
Case study
In-tech transfer of a cell line
Technical transfer
Productivity
assessment
Selection of 3 best clones
Sub-Cloning I
Failed
Tech. meeting
SE/Merck
Media and Feed
Screening
New medium:
ActiCHO
Sub-cloning II
Failed
Technical meeting
SE/M
June 2015 July 2015 Sept 2015 Nov. 2015 March 2016 May 2016
Current Working Data
 Final version of cloning report: after review from SE based on Merck comments
 Final version of cell line generation report: provided by Customer in order to know all process of pool generation
 From technical meeting SE/Merck (1)
• Composition of Cloning medium modified. (Gln  Gltmx).
 From technical meeting SE/Merck (2)
• Tech. Transfer document unfilled
• “A” clone has suffered during cloning process=> it is a “difficult” clone => The both failures of sub-cloning are
clone dependent. (and not due to a missing data)
• No defined process of sub-cloning from SE: performing of process dev. for each clone.
• Sub-cloning success rate from SE: 90% for sub-cloning of mAb secreting pool, 80% of failure in case of protein
secreting pool.
Case study
In-tech transfer of a cell line
The process has never been running twice within the same template
Robustness of the process has never been demonstrated
Case study
In-tech transfer of a stainless steel process to single use
Kick off
meeting
Team
members
Regulatory and
validation
requirements
Technical and
Quality Agreement
Planning
Communication
plan
Risk analysis
validated
Tech Transfer
Protocol
Reference
material provided
Tech
Transfer
report
Tech
Transfer
Closure
Experiments
Process is not robust, even Quality
Attributes of the product
Decision to redevelop a process
Tech transfer is not only related to the transfer of a process,
but to the transfer of a process and its associated issues
31 Managing process scaling and tech transfer
Questions?
Proven
Templates
Innovation
Knowledge
Transfer
Tech
Transfer
Managing Process Scale-up and Tech Transfer 

More Related Content

What's hot

Product Lifecycle Management Part 1 - ICHQ12.pptx
Product Lifecycle Management Part 1 - ICHQ12.pptxProduct Lifecycle Management Part 1 - ICHQ12.pptx
Product Lifecycle Management Part 1 - ICHQ12.pptx
GxPProfessional
 
Technology Transfer.pptx
Technology Transfer.pptxTechnology Transfer.pptx
Technology Transfer.pptx
SohailSheikh62
 
Tech transfer and Scale-up - Tips and tricks from a Biodevelopment center
Tech transfer and Scale-up - Tips and tricks from a Biodevelopment centerTech transfer and Scale-up - Tips and tricks from a Biodevelopment center
Tech transfer and Scale-up - Tips and tricks from a Biodevelopment center
Merck Life Sciences
 
Technology Tranfer models
Technology Tranfer modelsTechnology Tranfer models
Technology Tranfer models
Pritam Kolge
 
Technology transfer
Technology transferTechnology transfer
Technology transfer
SUMAN2611
 
Real time release testing
Real time release testing Real time release testing
Technology transfer from R & D to production in pharmaceutical industry
Technology transfer from R & D to production in pharmaceutical industryTechnology transfer from R & D to production in pharmaceutical industry
Technology transfer from R & D to production in pharmaceutical industry
Sagar Dhadwad
 
CASE STUDY ON CHANGE CONTROL
CASE STUDY ON CHANGE CONTROLCASE STUDY ON CHANGE CONTROL
CASE STUDY ON CHANGE CONTROL
JAYA PRAKASH VELUCHURI
 
Transforming Technology Transfer and Recipe Management: From Spreadsheets to ...
Transforming Technology Transfer and Recipe Management: From Spreadsheets to ...Transforming Technology Transfer and Recipe Management: From Spreadsheets to ...
Transforming Technology Transfer and Recipe Management: From Spreadsheets to ...
guest070fdd
 
Technology transfer plan & exhibit
Technology transfer plan & exhibit Technology transfer plan & exhibit
Technology transfer plan & exhibit
Akshay Nehe
 
Technology transfer models.pptx
Technology transfer models.pptxTechnology transfer models.pptx
Technology transfer models.pptx
sneha_pharmacist
 
Process analytical technology
Process analytical technologyProcess analytical technology
Process analytical technology
anjalibharat19
 
Technology Transfer and Scale-up in Pharmaceutical Industry
Technology Transfer and Scale-up in Pharmaceutical IndustryTechnology Transfer and Scale-up in Pharmaceutical Industry
Technology Transfer and Scale-up in Pharmaceutical Industry
PranjalWagh1
 
Pharmaceutical Manufacturing Operations
Pharmaceutical Manufacturing OperationsPharmaceutical Manufacturing Operations
Pharmaceutical Manufacturing Operations
Obaid Ali / Roohi B. Obaid
 
Training technology transfer training
Training technology transfer trainingTraining technology transfer training
Training technology transfer training
Steven (Steve) Laurenz
 
PLCM - Categorisation - ICHQ12.pptx
PLCM - Categorisation - ICHQ12.pptxPLCM - Categorisation - ICHQ12.pptx
PLCM - Categorisation - ICHQ12.pptx
GxPProfessional
 
Technology transfer
Technology transferTechnology transfer
Technology transfer
Steve Halls
 
Technology transfer
Technology transferTechnology transfer
Technology transfer
PRANJAY PATIL
 
QUALITY MANAGEMNT SYSTEMS: Change Control (CC)
QUALITY MANAGEMNT SYSTEMS: Change Control (CC)QUALITY MANAGEMNT SYSTEMS: Change Control (CC)
QUALITY MANAGEMNT SYSTEMS: Change Control (CC)
Dr Ajay Kumar Tiwari
 
Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]
Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]
Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]Flu Plant
 

What's hot (20)

Product Lifecycle Management Part 1 - ICHQ12.pptx
Product Lifecycle Management Part 1 - ICHQ12.pptxProduct Lifecycle Management Part 1 - ICHQ12.pptx
Product Lifecycle Management Part 1 - ICHQ12.pptx
 
Technology Transfer.pptx
Technology Transfer.pptxTechnology Transfer.pptx
Technology Transfer.pptx
 
Tech transfer and Scale-up - Tips and tricks from a Biodevelopment center
Tech transfer and Scale-up - Tips and tricks from a Biodevelopment centerTech transfer and Scale-up - Tips and tricks from a Biodevelopment center
Tech transfer and Scale-up - Tips and tricks from a Biodevelopment center
 
Technology Tranfer models
Technology Tranfer modelsTechnology Tranfer models
Technology Tranfer models
 
Technology transfer
Technology transferTechnology transfer
Technology transfer
 
Real time release testing
Real time release testing Real time release testing
Real time release testing
 
Technology transfer from R & D to production in pharmaceutical industry
Technology transfer from R & D to production in pharmaceutical industryTechnology transfer from R & D to production in pharmaceutical industry
Technology transfer from R & D to production in pharmaceutical industry
 
CASE STUDY ON CHANGE CONTROL
CASE STUDY ON CHANGE CONTROLCASE STUDY ON CHANGE CONTROL
CASE STUDY ON CHANGE CONTROL
 
Transforming Technology Transfer and Recipe Management: From Spreadsheets to ...
Transforming Technology Transfer and Recipe Management: From Spreadsheets to ...Transforming Technology Transfer and Recipe Management: From Spreadsheets to ...
Transforming Technology Transfer and Recipe Management: From Spreadsheets to ...
 
Technology transfer plan & exhibit
Technology transfer plan & exhibit Technology transfer plan & exhibit
Technology transfer plan & exhibit
 
Technology transfer models.pptx
Technology transfer models.pptxTechnology transfer models.pptx
Technology transfer models.pptx
 
Process analytical technology
Process analytical technologyProcess analytical technology
Process analytical technology
 
Technology Transfer and Scale-up in Pharmaceutical Industry
Technology Transfer and Scale-up in Pharmaceutical IndustryTechnology Transfer and Scale-up in Pharmaceutical Industry
Technology Transfer and Scale-up in Pharmaceutical Industry
 
Pharmaceutical Manufacturing Operations
Pharmaceutical Manufacturing OperationsPharmaceutical Manufacturing Operations
Pharmaceutical Manufacturing Operations
 
Training technology transfer training
Training technology transfer trainingTraining technology transfer training
Training technology transfer training
 
PLCM - Categorisation - ICHQ12.pptx
PLCM - Categorisation - ICHQ12.pptxPLCM - Categorisation - ICHQ12.pptx
PLCM - Categorisation - ICHQ12.pptx
 
Technology transfer
Technology transferTechnology transfer
Technology transfer
 
Technology transfer
Technology transferTechnology transfer
Technology transfer
 
QUALITY MANAGEMNT SYSTEMS: Change Control (CC)
QUALITY MANAGEMNT SYSTEMS: Change Control (CC)QUALITY MANAGEMNT SYSTEMS: Change Control (CC)
QUALITY MANAGEMNT SYSTEMS: Change Control (CC)
 
Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]
Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]
Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]
 

Viewers also liked

An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
Merck Life Sciences
 
The Role of BPOG Extractables Data in the Effective Adoption of Single-Use Sy...
The Role of BPOG Extractables Data in the Effective Adoption of Single-Use Sy...The Role of BPOG Extractables Data in the Effective Adoption of Single-Use Sy...
The Role of BPOG Extractables Data in the Effective Adoption of Single-Use Sy...
Merck Life Sciences
 
Venture Capital Funding: An Insider’s View
Venture Capital Funding: An Insider’s ViewVenture Capital Funding: An Insider’s View
Venture Capital Funding: An Insider’s View
Merck Life Sciences
 
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Merck Life Sciences
 
Integrity Test Troubleshooting – Beyond Rewet and Retest
Integrity Test Troubleshooting – Beyond Rewet and RetestIntegrity Test Troubleshooting – Beyond Rewet and Retest
Integrity Test Troubleshooting – Beyond Rewet and Retest
Merck Life Sciences
 
Serum-free Media for Therapeutic Cell Manufacturing – Challenges and Innovations
Serum-free Media for Therapeutic Cell Manufacturing – Challenges and InnovationsSerum-free Media for Therapeutic Cell Manufacturing – Challenges and Innovations
Serum-free Media for Therapeutic Cell Manufacturing – Challenges and Innovations
Merck Life Sciences
 
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
Merck Life Sciences
 
The Comprehensive Guide to Genotoxicity Assessment
The Comprehensive Guide to Genotoxicity AssessmentThe Comprehensive Guide to Genotoxicity Assessment
The Comprehensive Guide to Genotoxicity Assessment
Merck Life Sciences
 
Time is of the Essence: Creating a New Synergy Between Single-Use Adopters an...
Time is of the Essence: Creating a New Synergy Between Single-Use Adopters an...Time is of the Essence: Creating a New Synergy Between Single-Use Adopters an...
Time is of the Essence: Creating a New Synergy Between Single-Use Adopters an...
Merck Life Sciences
 
Rapid Methodologies for Biosafety Testing of Biologic Therapeutics
Rapid Methodologies for Biosafety Testing of Biologic TherapeuticsRapid Methodologies for Biosafety Testing of Biologic Therapeutics
Rapid Methodologies for Biosafety Testing of Biologic Therapeutics
Merck Life Sciences
 
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Merck Life Sciences
 
Delivering More Efficient Therapeutic Protein Expression Systems Through Cell...
Delivering More Efficient Therapeutic Protein Expression Systems Through Cell...Delivering More Efficient Therapeutic Protein Expression Systems Through Cell...
Delivering More Efficient Therapeutic Protein Expression Systems Through Cell...
Merck Life Sciences
 
Cells Powerpoint Presentation
Cells Powerpoint PresentationCells Powerpoint Presentation
Cells Powerpoint Presentationcprizel
 

Viewers also liked (13)

An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
 
The Role of BPOG Extractables Data in the Effective Adoption of Single-Use Sy...
The Role of BPOG Extractables Data in the Effective Adoption of Single-Use Sy...The Role of BPOG Extractables Data in the Effective Adoption of Single-Use Sy...
The Role of BPOG Extractables Data in the Effective Adoption of Single-Use Sy...
 
Venture Capital Funding: An Insider’s View
Venture Capital Funding: An Insider’s ViewVenture Capital Funding: An Insider’s View
Venture Capital Funding: An Insider’s View
 
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
 
Integrity Test Troubleshooting – Beyond Rewet and Retest
Integrity Test Troubleshooting – Beyond Rewet and RetestIntegrity Test Troubleshooting – Beyond Rewet and Retest
Integrity Test Troubleshooting – Beyond Rewet and Retest
 
Serum-free Media for Therapeutic Cell Manufacturing – Challenges and Innovations
Serum-free Media for Therapeutic Cell Manufacturing – Challenges and InnovationsSerum-free Media for Therapeutic Cell Manufacturing – Challenges and Innovations
Serum-free Media for Therapeutic Cell Manufacturing – Challenges and Innovations
 
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
 
The Comprehensive Guide to Genotoxicity Assessment
The Comprehensive Guide to Genotoxicity AssessmentThe Comprehensive Guide to Genotoxicity Assessment
The Comprehensive Guide to Genotoxicity Assessment
 
Time is of the Essence: Creating a New Synergy Between Single-Use Adopters an...
Time is of the Essence: Creating a New Synergy Between Single-Use Adopters an...Time is of the Essence: Creating a New Synergy Between Single-Use Adopters an...
Time is of the Essence: Creating a New Synergy Between Single-Use Adopters an...
 
Rapid Methodologies for Biosafety Testing of Biologic Therapeutics
Rapid Methodologies for Biosafety Testing of Biologic TherapeuticsRapid Methodologies for Biosafety Testing of Biologic Therapeutics
Rapid Methodologies for Biosafety Testing of Biologic Therapeutics
 
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
 
Delivering More Efficient Therapeutic Protein Expression Systems Through Cell...
Delivering More Efficient Therapeutic Protein Expression Systems Through Cell...Delivering More Efficient Therapeutic Protein Expression Systems Through Cell...
Delivering More Efficient Therapeutic Protein Expression Systems Through Cell...
 
Cells Powerpoint Presentation
Cells Powerpoint PresentationCells Powerpoint Presentation
Cells Powerpoint Presentation
 

Similar to Managing Process Scale-up and Tech Transfer 

6 Steps to Accelerate the Development Cycle | Life Science Parker Hannifin
6 Steps to Accelerate the Development Cycle | Life Science Parker Hannifin6 Steps to Accelerate the Development Cycle | Life Science Parker Hannifin
6 Steps to Accelerate the Development Cycle | Life Science Parker Hannifin
Parker Hannifin Corporation
 
Digital transformation through devops dod indianapolis
Digital transformation through devops dod indianapolisDigital transformation through devops dod indianapolis
Digital transformation through devops dod indianapolis
Peter Varhol
 
Pharmaceutical validation
Pharmaceutical  validationPharmaceutical  validation
Pharmaceutical validation
Pavisara
 
CV (Professional) - Mr Graham P Alvey
CV (Professional) - Mr Graham P AlveyCV (Professional) - Mr Graham P Alvey
CV (Professional) - Mr Graham P AlveyGraham Alvey
 
An Introduction to Clinical Study Migrations
An Introduction to Clinical Study MigrationsAn Introduction to Clinical Study Migrations
An Introduction to Clinical Study Migrations
Perficient, Inc.
 
Pharmaceutical Validation.pdf
Pharmaceutical Validation.pdfPharmaceutical Validation.pdf
Pharmaceutical Validation.pdf
Gireesh Kumar Eri
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
abdo badr
 
CV - Cathleen Thompson
CV - Cathleen Thompson CV - Cathleen Thompson
CV - Cathleen Thompson
Cathleen Thompson
 
Guidelines to Audit Validation Packages_RGA
Guidelines to Audit Validation Packages_RGAGuidelines to Audit Validation Packages_RGA
Guidelines to Audit Validation Packages_RGARosnelma García
 
V Edelstein Resume Progenics 12 10
V Edelstein Resume Progenics 12 10V Edelstein Resume Progenics 12 10
V Edelstein Resume Progenics 12 10dverae
 
PMP-Scope Management area
PMP-Scope Management areaPMP-Scope Management area
PMP-Scope Management area
Zaur Ahmadov, PMP
 
Computerized System Validation Business Intelligence Solutions
Computerized System Validation Business Intelligence SolutionsComputerized System Validation Business Intelligence Solutions
Computerized System Validation Business Intelligence Solutions
Digital-360
 
Product development and technology transfer M pharm
Product development and technology transfer M pharmProduct development and technology transfer M pharm
Product development and technology transfer M pharm
PoojaWadgave
 
pptonwho-200801140321.pdf
pptonwho-200801140321.pdfpptonwho-200801140321.pdf
pptonwho-200801140321.pdf
NikhilThakur992764
 
WHO guidelines on transfer of technology
WHO guidelines on transfer of technologyWHO guidelines on transfer of technology
WHO guidelines on transfer of technology
kavita bahmani
 
Feeling Good About Your Migration: A Field-proven Framework For Performing V...
Feeling Good About Your Migration: A Field-proven Framework For Performing V...Feeling Good About Your Migration: A Field-proven Framework For Performing V...
Feeling Good About Your Migration: A Field-proven Framework For Performing V...
BlueFish
 
Quality Assurance in Modern Software Development
Quality Assurance in Modern Software DevelopmentQuality Assurance in Modern Software Development
Quality Assurance in Modern Software Development
Zahra Sadeghi
 
Validation and calibration master plan
Validation and calibration master planValidation and calibration master plan
Validation and calibration master plan
Bharatlal Sain
 
Beating the product credit crunch
Beating the product credit crunchBeating the product credit crunch
Beating the product credit crunch
Stephen Williams
 

Similar to Managing Process Scale-up and Tech Transfer  (20)

6 Steps to Accelerate the Development Cycle | Life Science Parker Hannifin
6 Steps to Accelerate the Development Cycle | Life Science Parker Hannifin6 Steps to Accelerate the Development Cycle | Life Science Parker Hannifin
6 Steps to Accelerate the Development Cycle | Life Science Parker Hannifin
 
Digital transformation through devops dod indianapolis
Digital transformation through devops dod indianapolisDigital transformation through devops dod indianapolis
Digital transformation through devops dod indianapolis
 
Validation boot camp 2
Validation boot camp 2Validation boot camp 2
Validation boot camp 2
 
Pharmaceutical validation
Pharmaceutical  validationPharmaceutical  validation
Pharmaceutical validation
 
CV (Professional) - Mr Graham P Alvey
CV (Professional) - Mr Graham P AlveyCV (Professional) - Mr Graham P Alvey
CV (Professional) - Mr Graham P Alvey
 
An Introduction to Clinical Study Migrations
An Introduction to Clinical Study MigrationsAn Introduction to Clinical Study Migrations
An Introduction to Clinical Study Migrations
 
Pharmaceutical Validation.pdf
Pharmaceutical Validation.pdfPharmaceutical Validation.pdf
Pharmaceutical Validation.pdf
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
CV - Cathleen Thompson
CV - Cathleen Thompson CV - Cathleen Thompson
CV - Cathleen Thompson
 
Guidelines to Audit Validation Packages_RGA
Guidelines to Audit Validation Packages_RGAGuidelines to Audit Validation Packages_RGA
Guidelines to Audit Validation Packages_RGA
 
V Edelstein Resume Progenics 12 10
V Edelstein Resume Progenics 12 10V Edelstein Resume Progenics 12 10
V Edelstein Resume Progenics 12 10
 
PMP-Scope Management area
PMP-Scope Management areaPMP-Scope Management area
PMP-Scope Management area
 
Computerized System Validation Business Intelligence Solutions
Computerized System Validation Business Intelligence SolutionsComputerized System Validation Business Intelligence Solutions
Computerized System Validation Business Intelligence Solutions
 
Product development and technology transfer M pharm
Product development and technology transfer M pharmProduct development and technology transfer M pharm
Product development and technology transfer M pharm
 
pptonwho-200801140321.pdf
pptonwho-200801140321.pdfpptonwho-200801140321.pdf
pptonwho-200801140321.pdf
 
WHO guidelines on transfer of technology
WHO guidelines on transfer of technologyWHO guidelines on transfer of technology
WHO guidelines on transfer of technology
 
Feeling Good About Your Migration: A Field-proven Framework For Performing V...
Feeling Good About Your Migration: A Field-proven Framework For Performing V...Feeling Good About Your Migration: A Field-proven Framework For Performing V...
Feeling Good About Your Migration: A Field-proven Framework For Performing V...
 
Quality Assurance in Modern Software Development
Quality Assurance in Modern Software DevelopmentQuality Assurance in Modern Software Development
Quality Assurance in Modern Software Development
 
Validation and calibration master plan
Validation and calibration master planValidation and calibration master plan
Validation and calibration master plan
 
Beating the product credit crunch
Beating the product credit crunchBeating the product credit crunch
Beating the product credit crunch
 

More from Merck Life Sciences

Launch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeLaunch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide Alternative
Merck Life Sciences
 
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
Merck Life Sciences
 
Use of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationUse of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein Purification
Merck Life Sciences
 
Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...
Merck Life Sciences
 
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
Merck Life Sciences
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Merck Life Sciences
 
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
Merck Life Sciences
 
The Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsThe Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical Audits
Merck Life Sciences
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Merck Life Sciences
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesIdentity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Merck Life Sciences
 
Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...
Merck Life Sciences
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
Merck Life Sciences
 
Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?
Merck Life Sciences
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Merck Life Sciences
 
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Merck Life Sciences
 
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsRisk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Merck Life Sciences
 
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Merck Life Sciences
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
Merck Life Sciences
 
The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...
Merck Life Sciences
 
How to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesHow to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC Therapies
Merck Life Sciences
 

More from Merck Life Sciences (20)

Launch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeLaunch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide Alternative
 
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
 
Use of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationUse of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein Purification
 
Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...
 
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
 
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
 
The Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsThe Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical Audits
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesIdentity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapies
 
Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
 
Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
 
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...
 
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsRisk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
 
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
 
The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...
 
How to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesHow to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC Therapies
 

Recently uploaded

Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤
Dehradun ❤CALL Girls  8901183002 ❤ℂall  Girls IN Dehradun ESCORT SERVICE❤Dehradun ❤CALL Girls  8901183002 ❤ℂall  Girls IN Dehradun ESCORT SERVICE❤
Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤
aunty1x2
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
RitonDeb1
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
Naeemshahzad51
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
Sachin Sharma
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
rajkumar669520
 
Anatomy and Physiology Chapter-16_Digestive-System.pptx
Anatomy and Physiology Chapter-16_Digestive-System.pptxAnatomy and Physiology Chapter-16_Digestive-System.pptx
Anatomy and Physiology Chapter-16_Digestive-System.pptx
shanicedivinagracia2
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Dr. David Greene Arizona
 
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfNavigating the Health Insurance Market_ Understanding Trends and Options.pdf
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
Enterprise Wired
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
AnushriSrivastav
 
Secret Tantric VIP Erotic Massage London
Secret Tantric VIP Erotic Massage LondonSecret Tantric VIP Erotic Massage London
Secret Tantric VIP Erotic Massage London
Secret Tantric - VIP Erotic Massage London
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
Iris Thiele Isip-Tan
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
TheDocs
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
ranishasharma67
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
ssuser787e5c1
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
Iris Thiele Isip-Tan
 
Performance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility TestingPerformance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility Testing
Nguyễn Thị Vân Anh
 
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.pptGENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
Mangaiarkkarasi
 

Recently uploaded (20)

Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤
Dehradun ❤CALL Girls  8901183002 ❤ℂall  Girls IN Dehradun ESCORT SERVICE❤Dehradun ❤CALL Girls  8901183002 ❤ℂall  Girls IN Dehradun ESCORT SERVICE❤
Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
 
Anatomy and Physiology Chapter-16_Digestive-System.pptx
Anatomy and Physiology Chapter-16_Digestive-System.pptxAnatomy and Physiology Chapter-16_Digestive-System.pptx
Anatomy and Physiology Chapter-16_Digestive-System.pptx
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
 
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfNavigating the Health Insurance Market_ Understanding Trends and Options.pdf
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
 
Secret Tantric VIP Erotic Massage London
Secret Tantric VIP Erotic Massage LondonSecret Tantric VIP Erotic Massage London
Secret Tantric VIP Erotic Massage London
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
 
Performance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility TestingPerformance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility Testing
 
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.pptGENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
 

Managing Process Scale-up and Tech Transfer 

  • 1. Guillaume PLANE Provantage ® End-To-End Solutions NOT FOR U.S. AND CANADA AUDIENCE Managing process scaling and tech transfer
  • 2. 2 Managing process scaling and tech transfer Let us start with ICH Q10… “The goal of technology transfer activities is to transfer product and process knowledge between development and manufacturing, and within or between manufacturing sites to achieve product realization. This knowledge forms the basis for the manufacturing process, control strategy, process validation approach, and ongoing continual improvement.”  Transfers have to be performed in an organized, methodical manner, with appropriate documentation.  We will focus on the transfer of Drug Substance process parameters and process knowledge (data). Technology Transfer
  • 3. 3 Managing process scaling and tech transfer Process transfers include: • Transfer from one Process Development group to another, or to Pilot Lab • Transfer from Process Development to clinical or commercial manufacturing • Transfer from Process Development to external clinical manufacturing • Transfer of commercial process between company facilities • Transfer of commercial process to external contract manufacturing Greater rigor and documentation are needed for the latter cases, especially transfers between companies. Best practices discussed here cover the greater level of detail Scale as appropriate for the situation Scope of Process Transfers
  • 4. 4 Managing process scaling and tech transfer Mobius® 2,000 L Single-Use Bioreactor Performances Production of a mAb with a CHO-S cell line Define Scale in Advance of Transfer
  • 5. 5 Managing process scaling and tech transfer Mobius® 2000L Single Use Bioreactor Performances Production of mAb with CHO-K1 cell line (Cellvento® CHO 220)
  • 6. 6 Managing process scaling and tech transfer 1. Form tech transfer teams and governance structures, define project charter with goals and timelines 2. Consolidate process knowledge into transferable documentation 3. Gap Analysis / Risk Assessment – leads to detailed project plan 4. Tech Transfer Execution (work the plan) 5. Process “Q/q”ualification – demonstrate technical success 6. Finalize transfer: documentation, support of regulatory activities, follow-up actions, plan for ongoing technical support, lessons learned Process Transfer: Key Activities Transfer does not end at completion of Qualification lots or approval, but extends over duration of manufacturing
  • 7. 7 Managing process scaling and tech transfer Write Request for Proposal (RFP) • Provide sufficient detail for accurate assessment Due Diligence • Assess capabilities • Capacity, facility, cGMP, personnel • High level gap analysis • Be ready to order long lead time equipment • Assess feasibility if significant process changes would be required Write contract • Be specific on deliverables and expectations • Ensure terms incentivize rigorous scientific behaviors Early Planning Stage: often precedes external transfers
  • 8. 8 Managing process scaling and tech transfer Key content and outcomes from this document must include: • A well-defined team structure • Sub-teams for different disciplines • Connect counterparts • Establish communication paths • A well defined governance structure to resolve issues • Aligned timelines, gating/review points, and goals for deliverables • Clearly described roles and responsibilities • Who will be responsible for ongoing support and troubleshooting throughout manufacturing? • Clearly established success criteria Set expectations and responsibilities between partners Project Charter
  • 9. 9 Managing process scaling and tech transfer A Process Description document with an overview of each step and key process parameters is required • Information should be described in a site- and scale-independent manner, to focus on intrinsic process requirements • Site-specific details from previous process installations should also be gathered as examples For example: • Buffers may have been prepared in batch or via in-line dilution • Bioreactors may have been operated with different sparger configurations Consolidated Process Knowledge Use an electronic file sharing system for document hosting– not email
  • 10. 10 Managing process scaling and tech transfer Additional Valuable Process Information Materials • BOM • Consumables: bags, filters, tubing, gaskets, o-rings, etc. • Vendors • Grade Analytics • Assays used as part of mfg process: pH, osmo, conductivity, OD • Assays required to support transfer of scale-down models Facility & Equipment Requirements • URS/FRS • Heating/cooling • Process gas flow rates and total capacity • Instrumentation and control capabilities • Materials of construction • Safety assessments, hazardous material containment/ disposal Other Sources of Process Information • PD reports • Validation reports • Batch records / SOPs • Historical trends of process and product data • License requirements • Small scale model instructions and data • Spreadsheet process models • Tacit knowledge: cell morphology, media color, etc.
  • 11. 11 Managing process scaling and tech transfer Thorough process walk through: • Based on Process Description document • Assesses detailed fit of process in receiving facility • Identifies areas where changes will be necessary or what differences are acceptable • Guides project work plan • Identifies needs for facility modifications Great process learning exercise for the receiving site! Gap Analysis Gaps can be addressed by changing equipment, procedures, or the process Changes may require specific new validation studies or may be covered through the Process Qualification validation
  • 12. 12 Managing process scaling and tech transfer If you have to make process changes… • Some process changes are inevitable based on major differences in facility, equipment, or operational practices • Proper experiments must be performed to determine acceptability of the change. Small- scale models may be a good tool for examining the effects of changes • Pre-defined success criteria are key to timely progress and decision making- Otherwise, how do you know if the proposed change is acceptable?
  • 13. 13 Managing process scaling and tech transfer Quality Risk Management What do we do with all these gaps we identified? Risks are inherent in technology transfers Identifying, assessing, and mitigating - or - accepting risks defines the project work scope of a transfer From ICH Q9, two primary principles of quality risk management are: • Evaluation of the risk to quality should be based on scientific knowledge and ultimately link to the protection of the patient • The level of effort, formality, and documentation of the quality risk management process should be commensurate with the level of risk
  • 14. 14 Managing process scaling and tech transfer Goal: To achieve readiness for process qualification Mitigate identified risks • Equipment/facility modifications and validations Execute process using small scale model – qualify model Full scale engineering or “water” runs Author and approve manufacturing instruction documents • Requires a well-organized system for tracking and managing edits Training of production and support staff Tech Transfer Execution Work the plan…
  • 15. 15 Managing process scaling and tech transfer Process “Q/q”ualification Demonstration that the process is performing correctly at the receiving unit This may be a formal validation exercise or a simple report following an early clinical campaign Important to have Pre-defined Success Criteria (may or may not be part of Validation protocol) • Key Process Performance Metrics • Step yields, impurities, growth rates, titers, etc. • Product Quality Ranges • Successful Validation At key “go/no-go” decision points, it is helpful for parties to have agreed in advance on what success looks like
  • 16. 16 Managing process scaling and tech transfer Review process performance • If there are issues to be corrected, assign actions and plan the work • If failures occurred due to flaws in the methods of transfer, amend transfer procedures for future executions Support Regulatory activities • Document preparation for submissions • Respond to questions • Preparation for inspections Implement systems for ongoing technical support of manufacturing Complete all documentation Finalize Transfer
  • 17. 17 Managing process scaling and tech transfer What if you don’t have to make any changes to your process? Provantage® End-to-End Value Existing Process New Process Re-fit Process New Facility - We develop your manufacturing process for you - We fit the process to the updated template while your facility is being built
  • 18. 18 Managing process scaling and tech transfer Provantage® End-to-End Value Proven Templates Innovation Knowledge Transfer Tech Transfer
  • 19. 19 Managing process scaling and tech transfer Template approach Save time and money thanks to our ClinicReady™ Template Clarification Affinity Chromatography Ultrafiltration Sterile filtration CEX Chromatography Bulk Drug Substance Bioreactor Virus removal AEX Chromatography
  • 20. 20 • At each end of stage, a « Gate Review » is performed to ensure that quality of deliverables is online with the initial target • The whole stage is then validated • Intermediates Go/No Go will also occur during a stage to start activities of the next stage • Allows a time optimization by perfoming tasks in parallel (fast-tracking) A stage-gate approach
  • 21. 21 Plant Design Equipment definition Module definition Integration Final modules Managing process scaling and tech transfer
  • 22. 22 Managing process scaling and tech transfer Plant Design
  • 23. 23 Managing process scaling and tech transfer A brand new facility in a little over a year L0: GMP Preclinical production L+2: Process development
  • 24. 24 Managing process scaling and tech transfer Upstream Suites Increased flexibility and lower cost production environment
  • 25. 25 Managing process scaling and tech transfer
  • 26. 26 Managing process scaling and tech transfer
  • 27. Tech Transfer Kick off meeting Team members Regulatory and validation requirements Technical and Quality Agreement Planning Communication plan Risk analysis validated Kick off meeting: Scope, transfer timelines and team members are defined Team members: At least composed of a project manager, a technical leader and a tech transfer team Communication plan: Deliverables Team members with their respective responsibilities Communication flow path Meeting frequency Tech transfer protocol: Equipment Raw materials and consumables Detailed process description including critical parameters Analytical methods Tech Transfer Protocol Reference material provided Tech Transfer report Tech Transfer Closure Experiments
  • 28. Goal: Select parameters from cloning to adapt cells to our internal platform for sub-cloning step Cloning report:  Draft version: incomplete (raw mat.) / mistakes (% DMSO) but enough data to launch the project  Cloning medium composition  Cloning efficiency  Direct contact with sending entity (SE) for further information (mail exchange)  Technical transfer for Downstream Processing & Analytical parts but no Upstream part:  SE did not perform a sub-cloning phase but only a cloning step  The sub-cloning phase would not be included in a Tech transfer document (SE expertise) Case study In-tech transfer of a cell line Technical transfer Productivity assessment Selection of 3 best clones Sub-Cloning I Failed Tech. meeting SE/Merck Media and Feed Screening New medium: ActiCHO Sub-cloning II Failed Technical meeting SE/M June 2015 July 2015 Sept 2015 Nov. 2015 March 2016 May 2016
  • 29. Current Working Data  Final version of cloning report: after review from SE based on Merck comments  Final version of cell line generation report: provided by Customer in order to know all process of pool generation  From technical meeting SE/Merck (1) • Composition of Cloning medium modified. (Gln  Gltmx).  From technical meeting SE/Merck (2) • Tech. Transfer document unfilled • “A” clone has suffered during cloning process=> it is a “difficult” clone => The both failures of sub-cloning are clone dependent. (and not due to a missing data) • No defined process of sub-cloning from SE: performing of process dev. for each clone. • Sub-cloning success rate from SE: 90% for sub-cloning of mAb secreting pool, 80% of failure in case of protein secreting pool. Case study In-tech transfer of a cell line
  • 30. The process has never been running twice within the same template Robustness of the process has never been demonstrated Case study In-tech transfer of a stainless steel process to single use Kick off meeting Team members Regulatory and validation requirements Technical and Quality Agreement Planning Communication plan Risk analysis validated Tech Transfer Protocol Reference material provided Tech Transfer report Tech Transfer Closure Experiments Process is not robust, even Quality Attributes of the product Decision to redevelop a process Tech transfer is not only related to the transfer of a process, but to the transfer of a process and its associated issues
  • 31. 31 Managing process scaling and tech transfer Questions? Proven Templates Innovation Knowledge Transfer Tech Transfer